Eloxx Pharmaceuticals Inc.

ELOX | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.45

+$0.27 (+2.05%)

At close: Oct 30, 2026, 4:00 PM ET

$13.20

-$0.25 (-1.86%)

Pre-market: Nov 2, 2026, 8:54 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	4.79M	111K	1.13M	19.47M	42.57M	24.72M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	30K
Receivables	n/a	2.72M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	55K	147K	414K	202K	377K	368K
Total Current Assets	5.27M	2.98M	1.55M	20.13M	43.48M	25.89M
Property-Plant & Equipment	n/a	n/a	164K	994K	1.66M	554K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	164K	994K	1.66M	584K
Total Assets	5.27M	2.98M	1.71M	21.12M	45.14M	26.48M
Account Payables	2.71M	5.35M	5.7M	3.02M	1.38M	481K
Deferred Revenue	n/a	13.35M	12.97M	n/a	n/a	n/a
Short-Term Debt	1M	6.52M	2.22M	4.69M	657K	5.63M
Other Current Liabilities	12.77M	95K	471K	14.63M	6.3M	2.38M
Total Current Liabilities	17.18M	27.31M	22.7M	23.09M	9.96M	9.84M
Long-Term Debt	n/a	n/a	1.61M	8.56M	12M	6.38M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	1.61M	8.69M	12.8M	6.41M
Total Liabilities	17.18M	27.31M	24.31M	31.78M	22.76M	16.25M
Total Debt	1M	6.52M	3.97M	13.38M	13.46M	12.04M
Book Value	-11.91M	-24.34M	-22.6M	-10.66M	22.38M	10.23M
Book Value Per Share	-10.61	-71.22	-96.70	-54.13	140.77	112.18
Common Stock	48K	35K	31K	22K	871K	404K
Retained Earnings	-300.58M	-294.59M	-291.44M	-274.39M	-238.32M	-171.6M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-11.91M	-24.34M	-22.6M	-10.66M	22.38M	10.23M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a